Top 10 investor.pacira.com Competitors

cytovance.com

Cytovance Biologics is a U.S.-based CDMO providing microbial and mammalian biologics development and cGMP manufacturing. We support programs from tech transfer, through early development, scale-up, and commercial supply.

investor.ironwoodpharma.com

– LINZESS® (linaclotide) 2020 U.S. net sales of $931 million, up 10% year-over-year; Ironwood expects 2021 U.S. LINZESS net sales growth of 3 to 5% – – 2020 total revenue of $390 million, driven primarily by $369 million in U.S. LINZESS collaboration revenue – – 2020 GAAP net income was $106 million and adjusted EBITDA was $161 million; ended 2020 with $363 million in cash and cash equivalents – – Full year 2021 total revenue guidance of $370 to $385 million and adjusted EBITDA guidance of >$

qualicaps.com

qualicaps manufactures empty two-piece hard capsules for solid oral dosage forms and for use in dry powder inhalers, as well as a broad line of processing equipment for the pharmaceutical and health&nutrition industries.

durect.com

Learn about Bausch Health, a global company whose mission is to improve people’s lives with our health care products.

mercknewsroom.com

At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.

medpace.com

As part of one of the world's leading CROs, Medpace employees are truly making a difference in the lives of patients around the globe.

cromospharma.com

Our risk sharing program No Patients - No Payment™ ensures that patient enrolment goals, budgets, and timelines are met.

evaluate.com

Trusted commercial intelligence, consensus forecasts, news and analysis for pharma, biotech and medtech industry - Explore Evaluate

menarini.com

All’insegna dello sport e del Fair Play per celebrare i campioni che hanno saputo vincere senza barare, contando sulle proprie capacità, senza mollare mai.